EMA — Withdrawn Medicines & Recalls (FDA MedWatch)

EMA — Withdrawn Medicines & Recalls is the official source of medicine shortage information for United States (Americas). Mederti checks its register daily and links every notice back to the original publication.

Official register

www.fda.gov

Country

United States

Notices tracked by Mederti

2,619

Last checked

31 Oct 2026

Latest notices from FDA MedWatch

• Metoclopramide Tablets — active, high, since 6 Oct 2026 (source)
• Hydrocortisone-Hydrogen-Succinate — active, high, since 1 Oct 2026 (source)
• Metoclopramide Tablets — active, high, since 29 Sept 2026 (source)
• Lidocaine Ointment Usp — active, high, since 28 Sept 2026 (source)
• Tretinoin; Clindamycin — active, medium, since 25 Sept 2026 (source)
• Sermorelin — active, high, since 25 Sept 2026 (source)
• Tirzepatide/Cyanocobalamin Injectable — active, high, since 24 Sept 2026 (source)
• Imaavy Solution — active, high, since 23 Sept 2026 (source)
• Paroxetine — active, high, since 23 Sept 2026 (source)
• Amazon — active, medium, since 18 Sept 2026 (source)
• Fosfomycin Tromethamine — active, high, since 18 Sept 2026 (source)
• Focus Pi Hypromellose 0.7% Formula — active, high, since 17 Sept 2026 (source)
• Clear Eyes Redness Relief — active, high, since 15 Sept 2026 (source)
• Nystatine — active, medium, since 14 Sept 2026 (source)
• Eye Drops Maximum — active, high, since 11 Sept 2026 (source)

Mederti is not affiliated with or endorsed by EMA — Withdrawn Medicines & Recalls. All notices remain the property of their publisher and are linked to the original source.